5-bromo-2-(3,5-dimethylbenzyloxy)phenylacetic acid | 1018959-49-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 5-bromo-2-(3,5-dimethylbenzyloxy)phenylacetic acid
• 英文别名: 2-[5-Bromo-2-[(3,5-dimethylphenyl)methoxy]phenyl]acetic acid
• CAS: 1018959-49-3
• 化学式: C₁₇H₁₇BrO₃
• 分子量: 349.224
• InChiKey: WPKJRIQZKGGMHR-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  21
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.24
• 拓扑面积：
  46.5
• 氢给体数：
  1
• 氢受体数：
  3

文献信息

• Carboxilic acid derivatives
  申请人：YAMAGUCHI Youichi

  公开号：US20080275116A1

  公开（公告）日：2008-11-06

  A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): wherein R 1 represents a C 6-10 aryl group; or a substituted C 6-10 aryl group, R 2 represents a C 6-10 aryl group; or a C 6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, nitro group, a C 1-6 alkyl group, a halogenated C 1-6 alkyl group, a C 1-6 alkoxy group, a halogenated C 1-6 alkoxy group, a phenyl group and carboxy group, X represents —CH 2 —, —CH 2 CH 2 —, —CH═CH— or —N(R 3 )—C(═O)—, Y represents carboxy group or a bioisostere of carboxy group, R 3 represents hydrogen atom, a C 1-4 alkyl group or a C 7-12 aralkyl group, m represents 0 or 1.

  以下通用公式（I）代表的化合物或其盐，或其水合物或溶剂合物，具有对纤溶酶原激活抑制剂-1（PAI-1）的抑制作用：其中R1代表C6-10芳基；或取代的C6-10芳基，R2代表C6-10芳基；或取代的C6-10芳基，取代基或取代基组成的组中选择的卤素原子，硝基基团，C1-6烷基，卤代C1-6烷基，C1-6烷氧基，卤代C1-6烷氧基，苯基和羧基，X代表-CH2-，- -，-CH═CH-或-N（R3）-C（=O）-，Y代表羧基或羧基的生物同位素，R3代表氢原子，C1-4烷基或C7-12芳基烷基，m代表0或1。
• PAI-1 INHIBITOR
  申请人：Yamaguchi Youichi

  公开号：US20090312315A1

  公开（公告）日：2009-12-17

  The compound represented by the following formula (I) and the like have PAI-1 inhibition activity; wherein: R 1 represents a C 6-10 aryl group which may be substituted or the like; T represents a single bond or the like; m represents 0 or 1; when m is 0, G represents —N—C(═O)—CO 2 H or the like; when m is 1, G represents an oxygen atom or the like; R 2 represents a C 6-10 aryl group which may be substituted or the like; E represents the following formula (II) wherein one of R 31 , R 32 , R 33 and R 34 represents the formula R 1 -T-, each of the other three independently represents a hydrogen atom or the like, and R 35 represents the formula —X—Y′, a hydrogen atom or the like; X represents —CH 2 — or the like; Y′ represents a carboxy group or the like; M represents a single bond or the like.

  以下公式（I）表示的化合物及类似化合物具有PAI-1抑制活性；其中：R1代表可能被取代的C6-10芳基或类似基团；T代表单键或类似键；m代表0或1；当m为0时，G代表—N—C(═O)—CO2H或类似基团；当m为1时，G代表氧原子或类似基团；R2代表可能被取代的C6-10芳基或类似基团；E代表以下公式（II），其中R31、R32、R33和R34中的一个代表公式R1-T-，其余三个分别独立地代表氢原子或类似基团，R35代表公式—X—Y′，氢原子或类似基团；X代表—CH2—或类似基团；Y′代表羧基或类似基团；M代表单键或类似键。
• CARBOXYLIC ACID DERIVATIVE
  申请人：Institute of Medicinal Molecular Design, Inc.

  公开号：EP2080751A1

  公开（公告）日：2009-07-22

  A compound represented by the following general formula (I) or a salt thereof, or a hydrate thereof or a solvate thereof having an inhibitory action against plasminogen activator inhibitor-1 (PAI-1): wherein R1 represents a C6-10 aryl group; or a substituted C6-10 aryl group, R2 represents a C6-10 aryl group; or a C6-10 aryl group substituted with a group or groups selected from the group consisting of a halogen atom, nitro group, a C1-6 alkyl group, a halogenated C1-6 alkyl group, a C1-6 alkoxy group, a halogenated C1-6 alkoxy group, a phenyl group and carboxy group, X represents -CH2-, -CH2CH2-, -CH=CH- or -N(R3)-C(=O)-, Y represents carboxy group or a bioisostere of carboxy group, R3 represents hydrogen atom, a C1-4 alkyl group or a C7-12 aralkyl group, m represents 0 or 1.

  由下式通式（I）代表的化合物或其盐或其水合物或其溶液，对纤溶酶原激活物抑制剂-1（PAI-1）具有抑制作用： 其中 R1 代表 C6-10 芳基；或取代的 C6-10 芳基，R2 代表 C6-10 芳基；或被一个或多个基团取代的 C6-10 芳基，这些基团选自由卤素原子、硝基、C1-6 烷基、卤代 C1-6 烷基、C1-6 烷氧基、卤代 C1-6 烷氧基组成的组、X代表-CH2-、- -、-CH=CH-或-N(R3)-C(=O)-，Y代表羧基或羧基的生物异构体，R3代表氢原子、C1-4 烷基或 C7-12 芳基，m 代表 0 或 1。
• US8044236B2
  申请人：——

  公开号：US8044236B2

  公开（公告）日：2011-10-25
• US8633245B2
  申请人：——

  公开号：US8633245B2

  公开（公告）日：2014-01-21